Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients with Ovarian and Metastatic Breast Cancer

Trial Identifier: D0816R00025
Sponsor: AstraZeneca
NCTID:: NCT04330040
Start Date: May 2020
Primary Completion Date: September 2022
Study Completion Date: September 2022
Condition: Breast Cancer; Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Bengali Translation
Gujarati Translation
Hindi Translation
Malayalam Translation
Marathi Translation
Oriya Translation
Punjabi Translation
Tamil Translation
Telugu Translation

Trial Locations

Country Location
IN Ahmedabad, IN, 380009
IN Bhubaneswar, IN, 751007
IN Chandigarh, IN, 160012
IN Delhi, IN, 110029
IN Faridabad, IN, 121001
IN Guwahati, IN, 781023
IN Kochi, IN, 682041
IN Kolkata, IN, 700099
IN Kolkata, IN, 700160
IN Madurai, IN, 625107
IN Mumbai, IN, 400053
IN Mumbai, IN, 400012
IN New Delhi, IN, 110005
IN New Delhi, IN, 110 085
IN New Delhi, IN, 110063
IN Vellore, IN, 632004